share_log

Regeneron Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market

Regeneron Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market

Regeneron制药公司股价周三上涨，表现仍逊于大盘
DowjonesNews MarketWatch ·  2021/09/22 17:19

This article was automatically generated by MarketWatch using technology from Automated Insights.

本文由MarketWatch使用Automated Insights的技术自动生成。

Shares of Regeneron Pharmaceuticals Inc. (REGN) inched 0.02% higher to $647.06 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.95% to 4,395.64 and the Dow Jones Industrial Average  rising 1.00% to 34,258.32. This was the stock's second consecutive day of gains. Regeneron Pharmaceuticals Inc. closed $39.56 short of its 52-week high ($686.62), which the company achieved on September 3rd.

Regeneron制药公司(Regeneron PharmPharmticals Inc.)股价周三小幅上涨0.02%，至647.06美元，股市全面上涨，标准普尔500指数(S&P500 Index)上涨0.95%，至4,395.64点，道琼斯工业平均指数(Dow Jones Industrial Average)上涨1.00%，至34,258.32点。这是该股连续第二个交易日上涨。Regeneron制药公司(Regeneron PharmPharmticals Inc.)的收盘价比该公司9月3日创下的52周高点(686.62美元)低39.56美元。

The stock outperformed some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 0.36% to $163.93, Novartis AG ADR (NOVN.EB) fell 0.30% to $82.80, and Amgen Inc. (AMGN) fell 0.80% to $213.64. Trading volume (556,867) remained 167,268 below its 50-day average volume of 724,135.

该股周三表现优于部分竞争对手，强生(JNJ)跌0.36%，报163.93美元，诺华制药美国存托凭证(NOVN.EB)跌0.30%，报82.8美元，安进(AMGN)跌0.80%，报213.64美元。成交量(556,867口)仍比50天平均成交量724,135口低167,268口。

Data source: Dow Jones Market Data, FactSet. Data compiled September 22, 2021.

数据来源：道琼斯市场数据，FactSet。数据汇编于2021年9月22日。

-MarketWatch Automation

-MarketWatch自动化

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发